Civil Rights
Block on Trump's Asylum Ban Upheld by Supreme Court
In a patent infringement suit involving claims for certain tetrahydrobenzthiazole compounds for treatment of signs and symptoms of idiopathic Parkinson's disease, district court's judgment of invalidity is reversed and remanded where: 1) plaintiff's terminal disclaimer cannot overcome obviousness-type double patenting based on the '086 patent because the terminal disclaimer was filed after the expiration of the '086 patent; but 2) the district court incorrectly concluded that the safe-harbor provision of 35 U.S.C. section 121 is inapplicable in this case.
Read Boehringer Ingelheim Int'l GMBH v. Barr Lab, Inc., No. 09-1032
Appellate Information
Appealed from: United States District Court for the District of Delaware
Decided January 25, 2010
Judges
Before: Linn, Prost and Dyk, Circuit Judges
Opinion by Linn, Circuit Judge
Counsel
For Appellant: Bruce M. Wexler, Paul Hastings Janofsky & Walker LLP
For Appellee: Shannon M. Bloodworth, Perkins Coie LLP
Sign into your Legal Forms and Services account to manage your estate planning documents.
Sign InCreate an account allows to take advantage of these benefits: